Overview
Updated 14 Jul 2026
Robert Motzer, MD, is Genitourinary Medical Oncologist at Memorial Sloan Kettering Cancer Center. The public record shows 1,588 publications with 124,725 citations (h-index 150), centered on Renal cell carcinoma treatment, Renal and related cancers, Cancer Genomics and Diagnostics. It also documents an investigator role on 18 registered clinical trials, industry payments reported by 9 companies, 2 NIH-funded awards (1999–2011).
- Most recent indexed publication: 2026 · Nature reviews. Urology
- Top research focus: Renal cell carcinoma treatment
- 18 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 61 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 702.
Clinical & industrytrials, payments and federal funding
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 18 registered studies on ClinicalTrials.gov. The most recent:
- An Extension Treatment Protocol for Subjects Who Have Participated in a Study of Tivozanib Versus Sorafenib in Kidney Carcinoma (Protocol AV-951-09-301).
Sponsor: AVEO Pharmaceuticals, Inc.
InvestigatorPhase 3CompletedNCT01076010 - A Study to Compare Tivozanib (AV-951) to Sorafenib in Subjects With Advanced Renal Cell Carcinoma
Sponsor: AVEO Pharmaceuticals, Inc.
InvestigatorPhase 3CompletedNCT01030783 - Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors
Sponsor: Memorial Sloan Kettering Cancer Center
InvestigatorPhase 2CompletedNCT00470366
Industry payments
Updated 14 Jul 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20254 payments
- Merck Sharp & Dohme LLCProgram year20243 payments
- Merck Sharp & Dohme LLCProgram year20234 payments
NIH funding
Updated 14 Jul 2026
2 NIH research awards on record, funded 1999–2011 per NIH RePORTER. The latest:
- Molecular Basis Of Renal Cell Carcinoma Response to SU11428
Sloan-Kettering Inst Can Research
FY2011$336,532R01CA121327 - Molecular Basis Of Renal Cell Carcinoma Response to SU11428
Sloan-Kettering Inst Can Research
FY2010$346,940R01CA121327 - Molecular Basis Of Renal Cell Carcinoma Response to SU11428
Sloan-Kettering Inst Can Research
FY2009$346,940R01CA121327
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Sensitive CAR T cells redefine targetable CD70 expression in solid tumors.
Science (New York, N.Y.)
2026 - Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers.
CA: a cancer journal for clinicians
2026
Most-cited worksby citation count (OpenAlex)
- 01Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma5,896 citations2015
- 02Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma5,758 citations2007
- 03Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma4,647 citations2018
- 04
- 05Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma3,647 citations2007
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- Fellowship
Medical Oncology/Hematology, Memorial Sloan Kettering Cancer Center/Weill Cornell Medical College
1987verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Residency
Internal Medicine, North Shore University Hospital/Memorial Sloan Kettering Cancer Center
1984verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - MD
University of Michigan Medical School
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Board Certified
Internal Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Board Certified
Medical Oncology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Editorial & leadership rolesjournal and society appointments
- Section Head
Kidney Cancer, Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - Chair
NCCN Kidney Cancer (and Testicular Cancer) Clinical Practice Guidelines Panel
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →giantsofcancercare.com ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →giantsofcancercare.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mskcc.org ↗
Secondary affiliationsappointments beyond the home institution
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vivo.weill.cornell.edu ↗
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →healio.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →onclive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- Doximity
doximity.com/pub/robert-motzer-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/robert-motzer-bb28ba68
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - ResearchGate
researchgate.net/scientific-contributions/Robert-J-Motzer-38816777
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗
Mentions by otherswhere others cite or feature them
- Other
ascopost.com/videos/2021-asco-annual-meeting/robert-motzer-on-rcc-quality-of-life-for-patients-treated-with-lenvatinib-based-therapy-vs-sunitinib
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - Other
ascopost.com/videos/esmo-congress-2022/robert-motzer-on-renal-cell-carcinoma-new-results-with-nivolumab-and-ipilimumab
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ascopost.com ↗ - Other
reachmd.com/profiles/robert-j-motzer-md/L2312m/biography
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →reachmd.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Howard Scher, MD
Memorial Sloan Kettering Cancer Center
- 1,431
- publications
- 164
- h-index
- 8
- trials
Charles Sawyers, MD
Memorial Sloan Kettering Cancer Center
- 639
- publications
- 131
- h-index
- 4
- trials
Charles Rudin, MD
Memorial Sloan Kettering Cancer Center
- 1,717
- publications
- 135
- h-index
- 15
- trials
Sergio Giralt, MD
Memorial Sloan Kettering Cancer Center
- 1,809
- publications
- 122
- h-index
- 17
- trials